US2012258175A1PendingUtilityA1
Encapsulated bacteriophage formulation
Est. expiryNov 2, 2024(expired)· nominal 20-yr term from priority
A61P 31/04A61P 17/02A23K 50/75Y02A40/818C12N 2795/00032A23K 50/10A61K 35/76A23K 50/80C12N 2795/00051A23K 20/195
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An encapsulated bacteriophage formulation and a method for preparing encapsulated bacteriophage formulation is provided. The method for producing the encapsulated bacteriophage composition involves injection of a molten coating substance comprising stearic acid and palmitic acid present at a ratio of 50:50, into a granulator chamber containing immobilized bacteriophages. The immobilized bacteriophage are agitated by rotation of a base of the chamber and swept by a flow of air at a temperature of between 10° C. and 50° C.
Claims
exact text as granted — not AI-modified1 . A method for producing an encapsulated bacteriophage formulation comprising,
injecting a molten coating substance comprising stearic acid and palmitic acid at a ratio of 50:50 at a temperature of between about 20° C. and about 120° C. into a chamber containing bacteriophage immobilized on skim milk powder, the bacteriophage immobilized on skim milk powder agitated by rotation of a base of the chamber and swept by a flow of air at a temperature of between 10° C. and 50° C., the flow of air having a speed such that the chamber temperature is between about 30° C. to about 55° C., to produce an encapsulated bacteriophage formulation.
2 . The method according to claim 1 , wherein the speed of rotation of the base of the chamber is between 50 and 500 rpm.
3 . The method according to claim 1 , wherein the coating substance has a melting point of between 30° C. and 100° C.
4 . The method according to claim 1 , wherein the injection temperature is between 60° C. and 120° C.
5 . The method according to claim 1 , wherein the chamber temperature does not exceed by more than 5° C. a viability temperature of the immobilized bacteriophages.
6 . An encapsulated bacteriophage formulation comprising bacteriophage immobilized on skim milk powder and encapsulated with a coating substance comprising stearic acid and palmitic acid present at a ratio of 50:50.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.